
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


The Ensign Group Inc (ENSG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: ENSG (2-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $173
1 Year Target Price $173
4 | Strong Buy |
1 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 37.27% | Avg. Invested days 42 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.96B USD | Price to earnings Ratio 31.21 | 1Y Target Price 173 |
Price to earnings Ratio 31.21 | 1Y Target Price 173 | ||
Volume (30-day avg) 6 | Beta 1.02 | 52 Weeks Range 118.68 - 173.62 | Updated Date 08/28/2025 |
52 Weeks Range 118.68 - 173.62 | Updated Date 08/28/2025 | ||
Dividends yield (FY) 0.14% | Basic EPS (TTM) 5.53 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 7% | Operating Margin (TTM) 8.46% |
Management Effectiveness
Return on Assets (TTM) 5.3% | Return on Equity (TTM) 17.54% |
Valuation
Trailing PE 31.21 | Forward PE 26.88 | Enterprise Value 11556722033 | Price to Sales(TTM) 2.16 |
Enterprise Value 11556722033 | Price to Sales(TTM) 2.16 | ||
Enterprise Value to Revenue 2.5 | Enterprise Value to EBITDA 21.98 | Shares Outstanding 57700200 | Shares Floating 55243934 |
Shares Outstanding 57700200 | Shares Floating 55243934 | ||
Percent Insiders 3.43 | Percent Institutions 94.52 |
Upturn AI SWOT
The Ensign Group Inc

Company Overview
History and Background
The Ensign Group, Inc. was founded in 1999. It has grown from a small company with a few skilled nursing facilities to a large provider of healthcare services across the United States, primarily focused on post-acute care.
Core Business Areas
- Skilled Nursing Facilities: Provides a range of healthcare services, including rehabilitation, nursing, and assisted living, within owned and leased facilities. Focused on short-term rehabilitation patients as well as long-term care residents.
- Assisted Living Facilities: Offers personal care services, social activities, and assistance with daily living for seniors who require help with some tasks but not intensive medical care.
- Home Health and Hospice Services: Provides in-home healthcare services, including nursing care, therapy, and hospice care, through its network of agencies.
Leadership and Structure
Barry Port is the Chief Executive Officer. The company operates with a decentralized management structure, emphasizing local leadership and accountability. Corporate provides support services to the facilities.
Top Products and Market Share
Key Offerings
- Skilled Nursing Services: Rehabilitation services for patients recovering from surgery, injury, or illness. Competitors include Genesis Healthcare, Brookdale Senior Living and smaller regional players. Market share is fragmented, but Ensign is a significant player. Hard to determine precise market share due to market fragmentation and lack of detailed competitor revenue breakdown per service line.
- Assisted Living Services: Residential care for seniors needing assistance with daily living activities. Competitors include Brookdale Senior Living, Atria Senior Living, and Sunrise Senior Living. Similar to skilled nursing, market share is dispersed.
- Home Health and Hospice: In-home medical care and end-of-life care services. Competitors include LHC Group (now part of Optum), Amedisys, and Gentiva Health Services. Home Health is a competitive market.
Market Dynamics
Industry Overview
The healthcare industry is experiencing increasing demand due to the aging population and advancements in medical technology. The post-acute care sector is facing challenges related to reimbursement pressures, regulatory changes, and labor shortages.
Positioning
The Ensign Group positions itself as a high-quality, decentralized healthcare provider with a focus on delivering superior patient outcomes. Its decentralized model aims to empower local leaders and drive operational efficiency.
Total Addressable Market (TAM)
The TAM for post-acute care in the US is estimated to be in the hundreds of billions of dollars annually. Ensign is well-positioned to capture a larger share of this market through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Decentralized operating model
- Strong clinical outcomes
- Experienced management team
- Disciplined acquisition strategy
- Strong organic growth rates
Weaknesses
- Exposure to reimbursement risks
- Labor shortages
- Regulatory compliance challenges
- Geographic concentration in certain markets
- High debt levels
Opportunities
- Acquisitions of distressed assets
- Expansion into new markets
- Development of new service lines
- Partnerships with hospitals and health systems
- Increasing demand for post-acute care
Threats
- Changes in government regulations
- Increased competition
- Economic downturn
- Litigation risks
- Rising interest rates
Competitors and Market Share
Key Competitors
- GEN
- BKD
- FIVE
Competitive Landscape
Ensign competes primarily on quality of care, patient outcomes, and operational efficiency. Its decentralized model provides a competitive advantage. Actual market share is relatively low, it's a fragmented market with regional operators also competing.
Major Acquisitions
Multiple smaller acquisitions not individually noteworthy
- Year: 2023
- Acquisition Price (USD millions): 100
- Strategic Rationale: Continued growth and expansion into new markets.
Growth Trajectory and Initiatives
Historical Growth: Ensign has historically grown through organic growth and acquisitions.
Future Projections: Analyst projections vary, but typically predict continued revenue and earnings growth.
Recent Initiatives: Recent initiatives include acquisitions of new facilities, expansion into new markets, and investments in technology.
Summary
The Ensign Group operates within a fragmented healthcare industry, focusing on post-acute care. The company is growing steadily through acquisitions and organic initiatives. Regulatory hurdles and labor shortages represent potential risks. Ensign's decentralized structure offers a competitive edge. The company maintains a strong growth trajectory with favorable future projections from most analysts.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Relations Presentations
- Earnings Call Transcripts
- Third-Party Financial Data Providers (e.g., Yahoo Finance, Google Finance)
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual due diligence and consultation with a qualified financial advisor. Market share data is estimated due to the fragmented nature of the industry and limited public information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About The Ensign Group Inc
Exchange NASDAQ | Headquaters San Juan Capistrano, CA, United States | ||
IPO Launch date 2007-11-09 | CEO & Director Mr. Barry R. Port | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 39300 | Website https://ensigngroup.net |
Full time employees 39300 | Website https://ensigngroup.net |
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.